Gilead Sciences (UK) Today
| 0QYQ Stock | 90.22 0.27 0.30% |
Performance12 of 100
| Odds Of DistressLess than 9
|
Gilead Sciences is selling for under 90.22 as of the 28th of November 2024; that is 0.3% down since the beginning of the trading day. The stock's lowest day price was 90.22. Gilead Sciences has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Gilead Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Moving against Gilead Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Gilead Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Gilead Sciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Gilead Sciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman CEO | Daniel ODay |
| Business Concentration | Industrials, Commercial Services & Supplies, Commercial & Professional Services, Industrials (View all Sectors) |
Gilead Sciences (0QYQ) is traded on London Exchange in UK and employs 18,000 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 80.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Gilead Sciences's market, we take the total number of its shares issued and multiply it by Gilead Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Gilead Sciences operates under Commercial Services & Supplies sector and is part of Industrials industry.
Gilead Sciences generates positive cash flow from operations, but has no cash available
Check Gilead Sciences Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Gilead Sciences is USD80.16 Billion. The majority of Gilead Sciences outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Gilead Sciences to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Gilead Sciences. Please pay attention to any change in the institutional holdings of Gilead Sciences as this could imply that something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Gilead Ownership Details
Gilead Sciences Risk Profiles
Although Gilead Sciences' alpha and beta are two of the key measurements used to evaluate Gilead Sciences' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9248 | |||
| Semi Deviation | 0.9043 | |||
| Standard Deviation | 1.43 | |||
| Variance | 2.05 |
Gilead Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Gilead Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Gilead Sciences Corporate Management
Elected by the shareholders, the Gilead Sciences' board of directors comprises two types of representatives: Gilead Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gilead. The board's role is to monitor Gilead Sciences' management team and ensure that shareholders' interests are well served. Gilead Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gilead Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Quigley | VP Biology | Profile | |
| Johanna Mercier | Chief Officer | Profile | |
| Jyoti Mehra | Executive Resources | Profile | |
| Linda Higgins | Innovation Research | Profile | |
| Deborah Telman | General Affairs | Profile |
Additional Tools for Gilead Stock Analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.